Loading...

Chinese patients to gain access to the best of US healthcare

23-Sep-14, Pharmacy Choice

HelloMD (hellomd.com) announced that it has entered into a definitive agreement with Crosswave Management (crosswavemanagement.com) to provide Chinese patients with access to top US doctors.

The two companies will form a joint venture, based in China, to provide Chinese patients with access to doctors from the HelloMD network of leading US physicians. HelloMD lists only the top 1% of US doctors on its platform and provides direct access to these doctors for patients, both domestic and foreign, in addition to providing remote access services, including Second Opinions and Telehealth consultations.

"China's economic emergence over the last 30 years has created enormous demand for better medical services. Despite extraordinary gains in the quality and quantity of China's healthcare infrastructure, the gap between demand and supply of truly high-quality medical services continues to remain vast. We are excited to partner with HelloMD to offer Chinese patients access to the best the US has to offer," stated Charles Hsu, Managing Partner, Crosswave. "Chinese patients are already seeking alternatives to the overburdened, overcrowded hospitals in China. At the same time, many Chinese doctors welcome the opportunity to work with leading Western physicians to deliver the best possible care to their patients. We believe that putting Chinese patients and caregivers together with HelloMD's network of top doctors will benefit everyone involved," he continued.

 Read the full article

 

GGM perspective: While this example of innovative international telehealth or mHealth sounds great at first, how will the consultation actually work? Do many top US doctors speak Mandarin? Probably not. If the patient speaks English, is the level of understanding good to enough for the doctor to provide safe and useful advice? Our telemedicine advisor says that 80% of the value in a video consultation is actually in the audio conversation. A novel digital health development - we watch with interest.

 Insights 

Share